Formulation Excipients (Mannitol)
$0.07 bnAnnual import
20%Indian capability
5,022Supplier concentration (HHI)
₹1,508 crTo localise
Why India imports it. Reasoned estimate: India has limited domestic capacity for formulation excipients (mannitol); sector trade patterns indicate continued import reliance.
Why it matters. Strategic dependency within pharma value chain; affects downstream manufacturing competitiveness.
Can India localise it? Partial
Where it comes from. France (61%), China (24%), USA (15%).
Scorecard
The ten indices
CMDI 63.54Dependency
LPI 58Localisation potential
IAI 66.25Investment attractiveness
SRI 66.38Supply risk
SCI 51.5Supply-chain complexity
TRI 43.75Technology readiness
IMI 66.5Industrial multiplier
NSRI 57.25National-security relevance
EPI 65.25Export potential
ICGI 60.99Capability gap
Intelligence
Related signals
Sources
Primary references
Confidence: Reasoned estimate. Reasoned estimate derived from sector trade patterns and HS code classification; specific company/number values are modelled. Part of Techadyant Labs' Critical Manufacturing Dependencies (Edition I).